MBX-2982

MBX-2982

Catalog Number:
L002368743APE
Mfr. No.:
APE-A3587
Price:
$450
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          MBX-2982 is a potential first-in-class treatment for type 2 diabetes that targets G protein-coupled receptor 119 (GPR119), a receptor that interacts with bioactive lipids known to stimulate glucose-dependent insulin secretion. Preclinical data indicate that MBX-2982 is a potent selective orally-active GPR119 agonist that functions through a unique dual mechanism of action. First, it acts directly on the beta cell to increase insulin secretion. In addition, MBX-2982 stimulates release of the incretin GLP-1 from the gut. This dual action is unique and may offer improved glucose homeostasis over existing diabetes therapies, with potential for weight loss and improved islet health.

      • Properties
        • Categories
          GPR119 agonist, selective and orally-available
          Alternative Name
          MBX 2982;MBX2982; 2-[1-(5-ethylpyrimidin-2-yl)piperidin-4-yl]-4-[[4-(tetrazol-1-yl)phenoxy]methyl]-1,3-thiazole
          CAS Number
          1037792-44-1
          Molecular Formula
          C22H24N8OS
          Molecular Weight
          448.54
          Purity
          98.00%
          Solubility
          Soluble in DMSO
          Storage
          Store at -20°C
          SMILES
          CCC1=CN=C(N=C1)N2CCC(CC2)C3=NC(=CS3)COC4=CC=C(C=C4)N5C=NN=N5

          * For Research Use Only

    We Also Recommend

    MC 1046

    $1,575

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.